As a trusted partner in drug discovery and development, Pharmacology Discovery Services offers a comprehensive portfolio of efficacy testing, pharmacokinetics, and rodent tolerability. With over 350 validated therapeutically focused disease efficacy models in six therapeutic areas (anti-microbial, inflammation/allergy, oncology, behavior and CNS, metabolism and gastrointestinal/renal), we provide flexible and collaborative custom programs to meet your specific needs.
PDS offering standard and custom unique efficacy models, including rodent migraine, humanized NASH, and Neisseria gonorrhoeae Azithromycin/Ceftriaxone non-susceptibility models, and providing long-term support for government and Carb-X funding program in in vivo microbial efficacy evaluation and discovery PK.